BioSpace News Archive

BioMidwest

Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase

Miromatrix Medical Inc. today announced that the company will participate in the Gilmartin Emerging Growth Company Showcase on August 31st, 2022.

August 23, 2022
·
1 min read
Business

IsoPlexis Announces the Appointment of former Luminex Corporation Chairman and CEO, Nachum “Homi” Shamir to its Board of Directors

IsoPlexis Corporation today announced the appointment of Nachum “Homi” Shamir to its Board of Directors as a Class II director.

August 23, 2022
·
6 min read
Drug Development

Foghorn Therapeutics Provides Further Update on FHD-286 Phase I Study in Relapsed/Refractory AML/MDS

Foghorn ® Therapeutics Inc. today announced that the U.S. Food and Drug Administration (FDA) has placed a full clinical hold on the Phase 1 dose escalation study of FHD-286.

August 23, 2022
·
4 min read
FDA

Synlogic Granted FDA Fast Track Designation for SYNB1353 for the Treatment of Homocystinuria (HCU)

Synlogic, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SYNB1353 for the potential treatment of homocystinuria (HCU).

August 23, 2022
·
6 min read
Biotech Bay

Lucira Health to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

Lucira Health, Inc. today announced that the company will participate in the Gilmartin Group Emerging Growth Company Showcase on August 31st , 2022.

August 23, 2022
·
1 min read
Business

GH Research Reports Second Quarter 2022 Financial Results and Provides Business Updates

GH Research PLC today reported financial results for the second quarter ended June 30, 2022 and gave updates on its business.

August 23, 2022
·
7 min read
BioMidwest

Digital Diagnostics Closes $75 million Series B Funding Round led by KKR

Digital Diagnostics , a leading artificial intelligence diagnostic health care technology company, today announced that it has successfully closed a $75 million Series B funding round.

August 23, 2022
·
5 min read
Biotech Beach

Modified bladder cancer treatment shows promise in animal studies

A modified tuberculosis vaccine developed at Texas Biomedical Research Institute could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.

August 23, 2022
·
3 min read
FDA

K36 Therapeutics Announces FDA Clearance of Investigational New Drug Application and Formation of Clinical Advisory Board for Lead Program KTX-1001

K36 Therapeutics, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) Application for the Company’s lead program KTX-1001.

August 23, 2022
·
4 min read
Biotech Beach

NuVasive to Participate in Upcoming Investor Conferences

NuVasive, Inc. announced today that management will participate in the following investor conferences.

August 23, 2022
·
2 min read